China National Medicines Corporation Ltd. (600511.SS) Stock
—
Valuation
Financials & Margins
About China National Medicines Corporation Ltd.
—
China National Medicines Corporation Ltd. is led by CEO Yuetao Liu, employs 3,024 people, headquartered in Beijing, CN, publicly traded since 2002.
China National Medicines Corporation Ltd. (600511.SS) stock trades at $26.91 with a market capitalization of $20.12B. The stock is valued at a price-to-earnings (P/E) ratio of 10.42, price-to-book of 1.07, price-to-sales of 0.38. Over the past 52 weeks the stock has ranged between $25.11 and $31.18, and currently trades 13.7% below its 52-week high. It pays a dividend yielding 3.00%.
On profitability, China National Medicines Corporation Ltd. generates a return on equity (ROE) of 9.88%, an operating margin of 3.34%, a net profit margin of 3.60%.
The balance sheet shows a debt-to-equity ratio of 0.03 (debt below half of shareholders' equity), a current ratio of 2.18.
600511.SS has an average daily trading volume of 4,557,982 shares, a beta of 0.18 (historically less volatile than the overall market), 0.75B shares outstanding.
Official website: www.cncm.com.cn
China National Medicines Corporation Ltd. (600511.SS) — frequently asked questions
What is China National Medicines Corporation Ltd. (600511.SS) stock price today?
China National Medicines Corporation Ltd. (600511.SS) is currently trading at $26.91, down 1.75% today.
What is 600511.SS P/E ratio?
China National Medicines Corporation Ltd.'s P/E ratio is 10.42. This is below the typical market average of roughly 18-22x. A low P/E can reflect a lower valuation, slower expected growth, or both.
What is 600511.SS return on equity (ROE)?
China National Medicines Corporation Ltd.'s return on equity (ROE) is 9.88%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is China National Medicines Corporation Ltd.'s market cap?
China National Medicines Corporation Ltd. has a market capitalization of $20.12B.
Does 600511.SS pay a dividend?
Yes. China National Medicines Corporation Ltd. currently yields 3.00%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 600511.SS carry?
China National Medicines Corporation Ltd. has a debt-to-equity ratio of 0.03. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 600511.SS's profit margin?
China National Medicines Corporation Ltd. reports a net profit margin of 3.60% — the share of revenue left after every cost, including tax and interest.
What sector is 600511.SS in?
China National Medicines Corporation Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 600511.SS listed on?
China National Medicines Corporation Ltd. trades on SHH under the ticker 600511.SS.
What is 600511.SS's 52-week range?
Over the last year China National Medicines Corporation Ltd. has traded between $25.11 and $31.18.
Related — Stocks
Popular Stocks
Screens 600511.SS currently matches
On the figures above, China National Medicines Corporation Ltd. passes the filters for 20 of our ready-made screens, among them Low PE Stocks, Dividend Stocks, Low Debt Dividend Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.